BAD HOMBURG, Germany--(BUSINESS WIRE)--Fresenius Medical Care AG & Co. KGaA, the world’s largest provider of dialysis products and services, today announced that it signed exclusive license agreements for the intravenous (IV) Iron products Venofer® (iron sucrose) and Ferinject® (ferric carboxymaltose) to treat iron deficiency anemia experienced by dialysis patients. Venofer® is the leading IV Iron product worldwide.
The agreement concerns all commercialization activities for these IV Iron products in the field of dialysis and is expected to become effective not later than January 1st, 2009.
As part of the 10-year Agreement for North America....
I think you are missing the point of Rockwell's SFP. SFP is given with the dialysis treatment and provides low levels of iron to the bloodstream over time as opposed to single high doses like Venofere and Ferinject.
Fresenius doesn't have the option to use SFP at this time since it hasn't been through clinical testing yet. Once it is proven out, who would not want to provide iron through dialysis if its CHEAPER to the dialysis provider and is more effective than other IV iron drugs? Effectiveness and cost will drive SFP in the marketplace if it proves out. Venofer may become completely obsolete.
I agree. Hard to understand the run up and then run down. I don't think its option related since the price would have to move up and stay up for them to sell which means lots of real buyers.
It could be the overall market sentiment with speculators moving in and out of small cap health companies. Last night Cramer recommended speculating in one speculative biotech in your portfolio. RMTI certainly fits that bill.
If the price of this stock is being manipulated, which I think it is, who is making or saving money by virtue of the price manipulation? Could this have something to do with all the options granted to directors of the company? Who stands to profit from the recent run-up, then collapse, of the stock price? I'm at a loss.